CSIMarket
 


Vir Biotechnology Inc   (VIR)
Other Ticker:  
 
 

VIR's Operating Income Growth by Quarter and Year

Vir Biotechnology Inc 's Operating Income results by quarter and year




VIR Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 571.75 -108.40 47.68
III Quarter September 194.96 -53.39 -87.62 -47.68
II Quarter June -225.22 61.02 -29.05 0.00
I Quarter March 1,013.83 -158.63 -71.91 0.00
FY   983.57 420.75 -296.98 0.00



VIR Operating Income third quarter 2022 Y/Y Growth Comment
Vir Biotechnology Inc in the third quarter 2022 achieved Operating Income of $ 194.96 millions compare to Operating Loss recorded in same quarter a year ago.

Looking into third quarter 2022 results within Biotechnology & Pharmaceuticals industry 6 other companies have achieved higher Operating Income growth. While Vir Biotechnology Inc ' s Operating Income no change of % ranks overall at the positon no. 361 in the third quarter 2022.

Explain Operating Income growth


VIR Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Vir Biotechnology Inc 's third quarter 2022 Operating Income $ 194.96 millions VIR's Income Statement
Vir Biotechnology Inc 's third quarter 2021 Operating Income $ -53.39 millions Quarterly VIR's Income Statement
New: More VIR's historic Operating Income Growth >>


VIR Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March 77.32 % - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #7
Healthcare Sector #25
Overall #361

Operating Income Y/Y Growth Statistics
High Average Low
278.66 % 93.23 % -17.97 %
(Mar 31 2022)   (Jun 30 2022)
Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #7
Healthcare Sector #25
Overall #361
Operating Income Y/Y Growth Statistics
High Average Low
278.66 % 93.23 % -17.97 %
(Mar 31 2022)   (Jun 30 2022)

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Vir Biotechnology Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
77.32 % 77.32 % 77.32 %
(Mar 31 2022)  


VIR's III. Quarter Q/Q Operating Income Comment
This turnaround III. Quarter 2022where Vir Biotechnology Inc delivered Operating Income of $ 194.96 millions should be starting point of better business climet.Vir Biotechnology Inc announced in the III. Quarter 2022 Operating Income of $ 194.96 millions compare to Operating Loss recorded in previos quarter.

Within Biotechnology & Pharmaceuticals industry Vir Biotechnology Inc achieved highest sequential Operating Income growth. While Vir Biotechnology Inc 's Operating Income growth quarter on quarter, overall rank is 0.


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Operating Income Q/Q Growth Statistics
High Average Low
77.32 % 77.32 % 77.32 %
(Mar 31 2022)  


VIR's III. Quarter Q/Q Operating Income Comment
This reversal of fortune III. Quarter 2022where Vir Biotechnology Inc published Operating Income of $ 194.96 millions may be considered as a inception of improved performance.Vir Biotechnology Inc announced in the III. Quarter 2022 Operating Income of $ 194.96 millions compare to Operating Loss recorded in previos quarter.

Within Biotechnology & Pharmaceuticals industry Vir Biotechnology Inc achieved highest sequential Operating Income growth. While Vir Biotechnology Inc 's Operating Income growth quarter on quarter, overall rank is 0.


Vir Biotechnology Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Operating Income 12 Months Ending $ 1,555.32 $ 1,306.97 $ 1,593.21 $ 420.75 $ -259.41
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking